Ocular Therapeutix (OCUL) Work In Process (2014 - 2026)

Ocular Therapeutix's Work In Process history runs 13 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• On a quarterly basis, Work In Process fell 31.19% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 31.19% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, up 15.58% from the prior year.
• Work In Process declined to $1.2 million in Q1 2026 per OCUL's latest filing, from $1.7 million in the prior quarter.
• Across five years, Work In Process topped out at $1.8 million in Q1 2025 and bottomed at $567000.0 in Q1 2022.
• The 5-year median for Work In Process is $1.0 million (2023), against an average of $1.1 million.
• Across the five-year window, Work In Process soared 97.27% in 2025 and sank 31.19% in 2026, its largest moves.
• Year by year, Work In Process stood at $899000.0 in 2022, then climbed by 12.57% to $1.0 million in 2023, then surged by 47.13% to $1.5 million in 2024, then increased by 15.58% to $1.7 million in 2025, then fell by 27.83% to $1.2 million in 2026.
• Per Business Quant, the three latest OCUL Work In Process figures stand at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.4 million (Q3 2025).